ibudilast and leukotriene b4

ibudilast has been researched along with leukotriene b4 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimoto, Y; Ohtsu, H; Takishima, T; Tamura, G; Yamauchi, K	1
Chan, CC; Greig, GM; Huang, Z; Liu, S; Natsumeda, Y; Noguchi, K; Salem, M; Zhang, L	1

Other Studies

2 other study(ies) available for ibudilast and leukotriene b4

Article	Year
Pharmacological effect of KC-404 on leukotriene release from human leukocytes induced by ionophore A23187. International archives of allergy and applied immunology, 1989, Volume: 89, Issue:2-3 Topics: Calcimycin; Histamine Release; Humans; In Vitro Techniques; Leukocytes; Leukotriene B4; Leukotrienes; Pyridines; SRS-A	1989
Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life sciences, 2006, May-01, Volume: 78, Issue:23 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Dose-Response Relationship, Drug; Humans; Leukotriene B4; Lipopolysaccharides; N-Formylmethionine Leucyl-Phenylalanine; Ophthalmic Solutions; Phosphodiesterase Inhibitors; Pyridines; Recombinant Proteins; Tumor Necrosis Factor-alpha	2006

Article

Year

Pharmacological effect of KC-404 on leukotriene release from human leukocytes induced by ionophore A23187.

International archives of allergy and applied immunology, 1989, Volume: 89, Issue:2-3

Topics: Calcimycin; Histamine Release; Humans; In Vitro Techniques; Leukocytes; Leukotriene B4; Leukotrienes; Pyridines; SRS-A

1989

Preferential inhibition of human phosphodiesterase 4 by ibudilast.

Life sciences, 2006, May-01, Volume: 78, Issue:23

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Dose-Response Relationship, Drug; Humans; Leukotriene B4; Lipopolysaccharides; N-Formylmethionine Leucyl-Phenylalanine; Ophthalmic Solutions; Phosphodiesterase Inhibitors; Pyridines; Recombinant Proteins; Tumor Necrosis Factor-alpha

2006